|        
FASEB Logo FASEB Logo

Breakthroughs & Horizons in Bioscience

The Breakthroughs in Bioscience series illustrates recent breakthroughs in biomedical research and their importance to society. It also highlights the important role animal models play in biomedical research and discovery. Horizons in Bioscience, on the other hand, describes scientific discoveries on the brink of clinical application. These one page documents are intended to supplement our longer Breakthroughs in Bioscience series.

Hard copies of both series are available upon request. Please include the desired article, quantity and purpose for the publication's use with your inquiry.

Below you will find our latest issues for both series.  Archived issues are available for download and categorized on the following pages:

Latest Breakthroughs in Bioscience

Cancer Immunotherapies: From Magic Bullets to Super T Cells - Immunotherapy encompasses multiple approaches, including harnessing or enhancing immune cells, hormones, and other weapons of the immune system to destroy tumor cells, as well as releasing the brakes on the immune response that tumors trigger. This new article takes the reader on a journey from the origins of using toxins to prime the body’s immune system to attack tumors through today’s advances that genetically alter immune cells to fight cancer.

 

Latest Horizons in Bioscience

Cannabis & Chronic Pain: Separating Science from Stigma – Due to its poor reputation, cannabis and cannabinoid research has languished over the past 50 years.  However, as regulations on its use are softened and scientists take a second look at its effect on the pain pathway, researchers verify its potential role in relieving chronic pain. As the opioid crisis ramps up, cannabinoids may be a useful weapon in fighting addiction while reducing pain.

 

Breakthroughs in Bioscience Subcommittee

The Breakthroughs in Bioscience Subcommittee is charged with choosing timely topics that demonstrate the critical link between basic research in the biomedical sciences and the improvement in the quality of medical care available to our citizens. These topics are then developed into articles that are easily accessible to a broad audience of non-scientists including legislators, policy makers, and the general public.

Paula Stern, PhD, Chair (ASBMR)
Marcas Bamman, PhD, FACSM (ACSM*)
Aditi Bhargava, PhD (TES*)
David B. Burr, PhD (AAA*)
Blanche Capel, PhD (SDB)
Deborah A. Cory-Slechta, PhD (SOT*)
Rao Divi, PhD (ad hoc)
Terry Gaasterland, PhD (ad hoc)
Marnie Halpern, PhD (SDB*)
Loraine Oman-Ganes, MD (ASHG*)
R. Brooks Robey, MD (APS*)
Scott I. Simon, PhD (BMES)
Deborah J. Veis (Novack), MD, PhD (ASBMR)
Katherine Wilkinson, PhD (APS)

*Designated society representative to subcommittee, SPC, or Board